Filter
25
Filtered Results: 25
Text search:
nirmatrelvir
Featured
Recommendations
12
New Publications
12
Language
Document type
Fact sheets
11
Guidelines
8
Studies & Reports
2
Strategic & Response Plan
2
Manuals
1
No document type
1
Countries / Regions
Latin America and the Carribbean
3
Global
1
Authors & Publishers
Publication Years
Category
COVID-19
2
Infection Control & Prevention (IPC)
1
Guidelines
1
Studies & Reports
1
Statistics
1
Pharmacy & Technologies
1
Toolboxes
Clinical Guidelines
18
COVAX Initiative
2
Situation Reports & Updates
1
Global Impact: Socio-economic, health services, TB & HIV
1
Access & Strategy
1
Fair Allocation & Ethical Aspects
1
SARS-CoV-2 Variants
1
Essential Medicines
1
Prices and Patents
1
Reports & Studies
1
Global Overview
1
Human Rights & the Right to Health
1
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
Reseña normativa de la OMS:
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
